Search filters

List of works by Maggie Chon U Cheang

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer

scientific article

A four-gene decision tree signature classification of triple-negative breast cancer: Implications for targeted therapeutics

article

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.

scientific article

Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma

scientific article published in April 2005

Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization

scientific article

Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in Triple Negative Breast Cancer: the TNT trial

scientific article published on 21 October 2020

Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases

scientific article published on 3 October 2007

Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

scientific article published on June 2008

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

scientific article

Breast cancer subtypes and the risk of local and regional relapse.

scientific article

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

scientific article published on 30 April 2018

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

scientific article

Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease.

scientific article

Chemotherapy benefit for 'ER-positive' breast cancer and contamination of nonluminal subtypes—waiting for TAILORx and RxPONDER.

scientific article published on 29 October 2014

Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival

scientific article published on 01 May 2005

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.

scientific article

Defining breast cancer intrinsic subtypes by quantitative receptor expression

scientific article published on 23 April 2015

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer.

scientific article published on 13 June 2017

Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES

scientific article published on 24 January 2019

Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors

scientific article published on 23 September 2019

Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer

scientific article published on 01 April 2017

Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.

scientific article

Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES. ⬇️

scientific article published on 24 November 2017

Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers

article

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

scientific article

GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value

scientific article published in February 2008

Gene expression profiling of breast cancer

scientific article

Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC).

scientific article published on 09 March 2016

Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses

scientific article published on 02 August 2019

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas

scientific article published on April 2016

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

scientific article

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

scientific article published on 10 November 2008

Identifying Biomarkers to Pair with Targeting Treatments within Triple Negative Breast Cancer for Improved Patient Stratification

scientific article published on 25 November 2019

Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival

scientific article published on 20 November 2006

Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients

scientific article published on 31 December 2019

Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.

scientific article published on 15 May 2011

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial

scientific article published on 29 September 2020

Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial

scientific article published on 28 October 2016

Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials

scientific article published on 25 November 2017

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

scientific article published on 12 May 2009

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

scientific article published on 01 November 2020

Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients

scientific article published on 01 October 2008

Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker

scientific article published on 01 November 2006

MDM2 protein expression is a negative prognostic marker in breast carcinoma.

scientific article published on January 2006

Metastatic behavior of breast cancer subtypes

scientific article published on 24 May 2010

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

scientific article

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer

scientific article published on 12 February 2013

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

scientific article published in August 2015

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

scientific article published on 14 November 2014

NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis

article

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer

article

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer

scientific article published in July 2006

Nuclear beta-catenin in mesenchymal tumors

scientific article published on 01 January 2005

P63 expression in lung carcinoma: a tissue microarray study of 408 cases

scientific article

PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.

scientific article published on 24 October 2016

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.

scientific article

Predicting drug responsiveness in human cancers using genetically engineered mice.

scientific article published on 18 June 2013

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

scientific article

Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.

scientific article published on 9 June 2016

Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†. ⬇️

scientific article published on 22 May 2015

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer

scientific article

Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patients

scientific article published on 14 February 2014

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial

scientific article published on 06 December 2018

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

article

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy

scientific article

Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.

scientific article published on 20 February 2012

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

scientific article

Supervised risk predictor of breast cancer based on intrinsic subtypes

scientific article (publication date: 10 March 2009)

TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays

article

The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis

scientific article published in June 2004

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

scientific article

Use of mutation profiles to refine the classification of endometrial carcinomas.

scientific article published on 18 July 2012

αB-crystallin Expression in Breast Cancer is Associated with Brain Metastasis

scientific article published on October 2015

Paulina is supported by:

About Paulina

Help